Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

NCT04605978 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Primary Sjögren's Syndrome

Interventions

DRUG: S95011 concentrate for solution for infusion
DRUG: Placebo concentrate for solution for infusion

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]